| Name | Title | Contact Details |
|---|
Cochlear Limited is the leading global expert in implantable hearing solutions. For more than 30 years Cochlear has helped over 400,000 people connect to the world of sound. With a global team of over 2,800 passionate experts, Cochlear is an organisation you can be proud to work for. Our people say making a difference in the lives of others is the number one reason they enjoy working at Cochlear. With a range of solutions for different types of hearing loss, Cochlear maintains the industry’s largest investment in R&D. To improve our products and services we currently work in collaboration with over 100 research partners based in 20 countries. Cochlear’s mission of “Hear now. And always” embodies our commitment to providing life-time support. To build a sustainable global business, we are continually strengthening our internal capability and infrastructure, through the development of our people, processes and systems. As we continue to launch new products and services, our employees experience growth, change and opportunity right across the business. Joining the Cochlear team would see you collaborating with dedicated colleagues who share Cochlear’s core values of customer satisfaction, mutual respect, continuous improvement and innovation, performance and professionalism. Whatever career you chose at Cochlear, you will find the work interesting, challenging and rewarding.
Spineovations is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OrbusNeich is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cytta Corporation was created to develop, integrate and enhance medical communication devices.
ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. ImpediMed`s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in breast cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm in female breast cancer patients.